Tsumura traces herb procurement back to the cost of cultivation
229FY2025 crude-drug procurement-price index, FY2006 = 100
¥114.629bnConsolidated raw materials and supplies at March 2026
129 formulationsPrescription Kampo products sold in Japan in FY March 2026
What emerges
See the company through the numbers →Tsumura connects cultivation guidance and knowledge of growing costs with the prices it pays for crude drugs. Sorting and blending those materials into products also involve inventory: consolidated raw materials and supplies stood at ¥114.629bn at March 2026. Securing inputs and moving them efficiently into the products needed are both part of supplying Kampo medicines.